NCT00466752 2017-11-22
Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer
University of Washington
Phase 2 Completed
University of Washington
Radiation Therapy Oncology Group
Barbara Ann Karmanos Cancer Institute